论文部分内容阅读
AFP为诊断原发性肝癌的肿瘤标记,已广泛应用于临床及肝癌早期普查。但部分原发性肝癌及转移性肝癌AFP则为阴性。因此选择其他有价值的肿瘤标记,实属必要。近年来以铁蛋白作为肝癌的肿瘤标记物已受到重视。本文初步探讨铁蛋白对AFP阴性的原发性肝癌及肝转移癌的诊断价值。病例及方法病例全部病例均经临床确诊。肝癌组原发性肝癌138例(男122例、女16例);转移性肝癌4例(均为男性)。对照组计慢性活动性肝炎6例,迁延
AFP is a tumor marker for the diagnosis of primary liver cancer and has been widely used in clinical and early detection of liver cancer. However, some patients with primary liver cancer and metastatic liver cancer were negative for AFP. Therefore, it is necessary to choose other valuable tumor markers. In recent years, ferritin has become a tumor marker for liver cancer. This article is a preliminary investigation of the diagnostic value of ferritin for AFP-negative primary liver cancer and liver metastases. Cases and Methods All cases were clinically confirmed. In the liver cancer group, 138 cases of primary liver cancer (122 males and 16 females) and 4 cases of metastatic liver cancer (all males). The control group counted 6 cases of chronic active hepatitis, protracted